Metronidazole Dosage
For adults, metronidazole is typically dosed at 500 mg IV every 6-8 hours or 500 mg orally three times daily, with adjustments required for severe hepatic impairment but not for renal dysfunction alone. For children, the standard dose is 7.5 mg/kg every 6 hours (not to exceed 4 g/24 hours) or 20-30 mg/kg/day divided into doses depending on the indication 1, 2.
Adult Dosing by Indication
Anaerobic Infections (Including Necrotizing Soft Tissue Infections)
- Standard IV dosing: 500 mg every 6-8 hours 3, 4, 5
- Alternative: 500 mg every 8-12 hours or 1500 mg every 24 hours 5
- Maximum: Do not exceed 4 g in 24 hours 1
- Duration: Typically 7-10 days, though bone/joint infections may require longer treatment 1
For mixed necrotizing infections, metronidazole is combined with cefotaxime (2 g every 6 hours IV) or used with aminoglycosides/fluoroquinolones for broader coverage 3, 4.
Oral Dosing for Specific Conditions
- Animal/human bites: 250-500 mg three times daily orally 3
- Intra-abdominal infections: 500 mg every 8-12 hours IV 5
- Amebiasis: 500-750 mg orally three times daily for 5-10 days 1
- Trichomoniasis: 2 g single dose or 250 mg three times daily for 7 days 1
Clostridioides difficile Infection
Metronidazole is no longer first-line for CDI. Use only for nonsevere initial episodes when vancomycin or fidaxomicin are unavailable: 500 mg orally three times daily for 10-14 days 6, 7. For fulminant CDI with ileus, give metronidazole 500 mg IV every 8 hours in combination with oral/rectal vancomycin 6, 7.
Pediatric Dosing
Standard Pediatric Doses
- Anaerobic infections: 7.5 mg/kg every 6 hours IV (approximately 30 mg/kg/day) 5, 1
- Alternative calculation: 20-30 mg/kg/day for children under 12 years 2
- Amebiasis: 35-50 mg/kg/24 hours divided into three doses for 10 days 1
- Necrotizing infections: 7.5 mg/kg every 6 hours IV 3, 4
For children ≥12 years, adult dosing may be used (200 mg to maximum 2000 mg per day) 2.
Critical Dosing Adjustments
Hepatic Impairment
This is the most important adjustment for metronidazole. Patients with severe liver disease metabolize metronidazole slowly, leading to drug and metabolite accumulation 1, 8, 9.
- Reduce doses below standard recommendations in severe hepatic disease 1
- Elimination half-life increases from 5.9 hours (normal) to 11.2 hours in hepatic insufficiency 8
- Hepatic metabolism of the hydroxy-metabolite is significantly impaired 9
- Monitor plasma metronidazole levels and watch for toxicity (particularly neurotoxicity with prolonged use) 1, 8
Single oral doses may not require adjustment in compensated cirrhosis, but repeated dosing necessitates reduction 10. The primary mechanism for delayed elimination is impaired hepatic drug metabolism, not renal clearance 9.
Renal Impairment
Do not reduce metronidazole doses in renal failure alone 1. The parent drug is not significantly affected by renal dysfunction, though metabolites accumulate 8. In anuric patients, accumulated metabolites are rapidly removed by dialysis, so dose reduction is unnecessary 1. However, metronidazole is removed during prolonged intermittent kidney replacement therapy, requiring monitoring 11.
Combined Hepatic and Renal Impairment
When both conditions coexist (common in critically ill patients), prioritize dose reduction for hepatic impairment and monitor closely 8, 9. The majority of patients with severe liver disease also have some renal dysfunction, making this scenario clinically relevant 9.
Important Clinical Caveats
Neurotoxicity Risk
Severe neurotoxicity (encephalopathy, cerebellar dysfunction, seizures) occurs with:
- Prolonged courses (>2 weeks)
- High cumulative doses (>73.5 g reported in fatal case) 12
- Hepatic impairment
- Poor nutritional status
- Advanced age 12
Avoid repeated or prolonged courses due to cumulative and potentially irreversible neurotoxicity 6. MRI findings (symmetric high signals in dentate nucleus, corpus callosum) help diagnose metronidazole-induced encephalopathy, which can be irreversible despite drug discontinuation 12.
Therapeutic Drug Monitoring
Trough serum concentrations of 3-11 mg/L are achieved with 12-hourly dosing (both oral and IV), well above MICs for most anaerobes 13. In elderly patients or those with hepatic disease, serum level monitoring may be necessary to adjust dosing 1.
Pregnancy Considerations
Avoid during first trimester 1. If treatment is necessary in pregnancy, use the seven-day regimen rather than single-dose therapy to avoid high peak fetal circulation levels 1.